Which Medical Device

New clinical data presented at the recent EuroPCR held in Paris (May) demonstrated positive long-term performance and durability for the CoreValve transcatheter aortic valve replacement system from Medtronic. Read more

Boston Scientific announced the US and European launches of the Sterling SL PTA balloon dilatation catheter, a high-performance balloon dilatation catheter designed for use in peripheral angioplasty procedures below-the-knee. The company plans to launch the product immediately in both markets. Read more

Stryker's Interventional Spine business unit announced the release of its iVAS inflatable vertebral augmentation system, a minimally invasive device cleared for use in treating vertebral compression fractures (VCFs). Read more

The first commercial implant recently took place in the US of the RENEW Interspinous Allograft Technology (Interventional Spine) for the treatment of lumbar spinal stenosis (LSS). Read more

Volcano Corporation has received CE mark approval for the VIBE RX Vascular Imaging Balloon Catheter. The company also announced that it has completed its first clinical cases with the VIBE RX in New Zealand. A single VIBE RX Catheter can quickly access, prepare, and assess challenging lesions. IVUS guidance provides precise, targeted balloon dilatation with immediate confirmation of interventional results. Read more

Medtronic announced in April 2010 that it has received approval from the FDA for the Complete SE Vascular Stent System to be used for the treatment of peripheral arterial disease (PAD) in the iliac arteries. Read more

The Quick-Close Vascular Suturing System from Interventional Therapies LLC received FDA clearance in April 2010. It consists of the Quick-Close Suture Applier and the Quick-Ti Cinch Applier. The suture applier has a pistol grip shape and contains a single strand of an artificial suture (polybutester Novafil) fitted with stainless steel rings. Read more

The completion of the first implants of the Zenith TX2 Low Profile TAA Endovascular Graft (Cook Medical) took place in May 2010, as part of a clinical investigation, by assistant Professor Piotr Kasprzak, head of vascular surgery at the University Hospital Regensburg, Germany. Read more

The new ExoSeal vascular closure device (Cordis) received CE mark in May 2010 and was recently launched at the EuroPCR meeting in Paris. The company states that it incorporates a number of new advances in technology and simplicity of design to provide precise and secure extravascular arterial closure. Read more

The first patients have been enrolled in the INNOVATION trial, which will assess the safety and performance of a new stent graft system, the Incraft (Cordis), to treat abdominal aortic aneurysm (AAA). Read more

AccessClosure has introduced its newest addition to the Mynx family, the Mynx M5 vascular closure device. Designed specifically for 5F closure, the Mynx M5 delivers an extravascular, conformable sealant through the existing 5F procedural sheath, eliminating the need for a sheath exchange and preserving the size of the arteriotomy. Read more